Pages that link to "Q59600751"
Jump to navigation
Jump to search
The following pages link to Discontinuation of Phenytoin, Carbamazepine, and Valproate in Patients with Active Epilepsy (Q59600751):
Displaying 10 items.
- Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects. (Q30249670) (← links)
- Medical assessment and treatment of chronic epilepsy (Q35185729) (← links)
- Electrocorticographic factors associated with temporal lobe epileptogenicity (Q40764080) (← links)
- Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations (Q43004735) (← links)
- Therapeutic intensive seizure analysis (TISA) in presurgical evaluation of Losigamone (Q43758637) (← links)
- Loreclezole monotherapy in patients with partial seizures (Q43988652) (← links)
- Modern treatment strategies for patients with epilepsy: a review. (Q55059340) (← links)
- Discontinuation of clonazepam in patients with active epilepsy (Q59600734) (← links)
- Effects of discontinuation of individual antiepileptic drugs on mood (Q59600735) (← links)
- Seizure recurrence and risk factors after withdrawal of chronic antiepileptic therapy in children (Q74649478) (← links)